Lazar Amends OpGen Stake Filing

TL;DR

Lazar updated his OpGen filing on 4/8, watch for details.

AI Summary

David E. Lazar, through an amendment filed on April 8, 2024, reported a change in his beneficial ownership of OpGen, Inc. common stock. The filing indicates a shift in his holdings, though specific new percentages or dollar amounts are not detailed in this excerpt. The event requiring this filing occurred on April 5, 2024.

Why It Matters

Changes in beneficial ownership filings like this can signal shifts in major shareholder sentiment or strategy, potentially impacting the stock price.

Risk Assessment

Risk Level: medium — Schedule 13D filings often indicate significant investor activity, which can introduce volatility.

Key Players & Entities

• David E. Lazar (person) — Filing person
• OpGen, Inc. (company) — Subject company
• April 8, 2024 (date) — Filing date
• April 5, 2024 (date) — Date of event requiring filing

FAQ

Key Financial Figures

• $0.01 — Inc . (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securiti
• $400,000 — y the Reporting Person is approximately $400,000. Pursuant to the SPA, the Reporting Per
• $2,600,000 — ares for an aggregate purchase price of $2,600,000, however the purchase of such additiona
• $200,000 — red Stock for a total purchase price of $200,000. 2 SIGNATURES After reasonable inqu

Filing Documents

• opgen_sc13da.htm (SC 13D/A) — 31KB
• 0001829126-24-002304.txt ( ) — 32KB

is hereby amended and

Item 3 is hereby amended and restated as follows: The 9,600,000 Shares purchased by the Reporting Person were purchased with personal funds pursuant to the SPA, as further described in Item 6 of the Schedule 13D filed by the Reporting Person on April 1, 2024 (the “Initial 13D”). The aggregate purchase price of the 9,600,000 Shares directly beneficially owned by the Reporting Person is approximately $400,000. Pursuant to the SPA, the Reporting Person has the right to purchase 62,400,000 additional Shares for an aggregate purchase price of $2,600,000, however the purchase of such additional Shares is subject to certain closing conditions as further described in the SPA. Item 5. Interest in Securities of the Issuer .

(a) – (c) is hereby

Item 5(a) – (c) is hereby amended and restated as follows: The aggregate percentage of Shares reported owned by each person named herein is based upon 12,014,376 shares of Common Stock outstanding, which is the total number of Shares outstanding as of April 3, 2024, as reported in the Issuer’s Information Statement on Schedule 14F-1 filed with the Securities and Exchange Commission on April 3, 2024. A. Reporting Person (a) As of the close of business on April 8, 2024, the Reporting Person beneficially owned 2,390,861 Shares. Percentage: Approximately 19.9% (b) 1. Sole power to vote or direct vote: 2,390,861 2. Shared power to vote or direct vote: 0 3. Sole power to dispose or direct the disposition: 2,390,861 4. Shared power to dispose or direct the disposition: 0 (c) The transactions in the Shares by the Reporting Person during the past sixty days are set forth in more detail in Item 6. Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer .

is hereby amended to

Item 6 is hereby amended to add the following: On April 5, 2024, the second closing under the SPA occurred whereby the Reporting Person acquired 200,000 shares of Series E Preferred Stock for a total purchase price of $200,000. 2

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of his knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct. Dated: April 8, 2024 /s/ David E. Lazar DAVID E. LAZAR 3

View Full Filing

View this SC 13D/A filing on SEC EDGAR